rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

SR ONE CAPITAL MANAGEMENT, LLC

10% owner

Company insider

Files Form 4 as: 10% owner, Andrx Corp /de/; 10% owner, Odyssey Therapeutics; 10% owner, Avalyn Pharma; 10% owner, Zenas BioPharma; 10% owner, Design Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
92
Buys
6
Sells
1
Bought
$119.8M
Sold
$32K
Companies
5
Companies where not an officer
5
First trade
30 Mar 2021
Last trade
28 Sep 2026
Last filed
29 Sep 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
Andrx Corp /de/10% owner · last 28 Sep 20261 buy · 0 sells
ODTX Odyssey Therapeutics10% owner · Biotechnology · last 11 May 20261 buy · 1 sell
AVLN Avalyn Pharma10% owner · Biotechnology · last 1 May 20261 buy · 0 sells
ZBIO Zenas BioPharma10% owner · Biotechnology · last 9 Oct 20252 buys · 0 sells
DSGN Design Therapeutics10% owner · Biotechnology · last 30 Mar 20211 buy · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
28 Sep 2026filed 29 Sep 2026Andrx Corp /de/SEC FORM 4 Code C—3,334,938filing
28 Sep 2026filed 29 Sep 2026Andrx Corp /de/option or derivativeSEC FORM 4 Code C—3,907,547 at $0.00filing
28 Sep 2026filed 29 Sep 2026Andrx Corp /de/option or derivativeSEC FORM 4 Code C—1,304,883 at $0.00filing
28 Sep 2026filed 29 Sep 2026Andrx Corp /de/option or derivativeSEC FORM 4 Code C—600,962 at $0.00filing
28 Sep 2026filed 29 Sep 2026Andrx Corp /de/option or derivativeSEC FORM 4 Code C—1,802,885 at $0.00filing
28 Sep 2026filed 29 Sep 2026Andrx Corp /de/option or derivativeSEC FORM 4 Code C—1,953,773 at $0.00filing
28 Sep 2026filed 29 Sep 2026Andrx Corp /de/option or derivativeSEC FORM 4 Code C—198,019 at $0.00filing
28 Sep 2026filed 29 Sep 2026Andrx Corp /de/SEC FORM 4 Code C—1,113,666filing
28 Sep 2026filed 29 Sep 2026Andrx Corp /de/SEC FORM 4 Code C—512,897filing
28 Sep 2026filed 29 Sep 2026ADRX ADARx Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code C—3,907,547 at $0.00filing
28 Sep 2026filed 29 Sep 2026ADRX ADARx Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code C—1,304,883 at $0.00filing
28 Sep 2026filed 29 Sep 2026ADRX ADARx Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code C—600,962 at $0.00filing
28 Sep 2026filed 29 Sep 2026ADRX ADARx Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code C—1,802,885 at $0.00filing
28 Sep 2026filed 29 Sep 2026ADRX ADARx Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code C—1,953,773 at $0.00filing
28 Sep 2026filed 29 Sep 2026ADRX ADARx Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code C—198,019 at $0.00filing
28 Sep 2026filed 29 Sep 2026Andrx Corp /de/SEC FORM 4 Bought$10.1M592,593 at $17.00filing
28 Sep 2026filed 29 Sep 2026Andrx Corp /de/SEC FORM 4 Code C—1,538,691filing
28 Sep 2026filed 29 Sep 2026Andrx Corp /de/SEC FORM 4 Bought$7.1M414,814 at $17.00filing
28 Sep 2026filed 29 Sep 2026Andrx Corp /de/SEC FORM 4 Code C—1,667,468filing
28 Sep 2026filed 29 Sep 2026Andrx Corp /de/SEC FORM 4 Code C—169,001filing

Sectors

Health Care7
Not placed1

Buys in green, sells in red, by the company’s sector.

Related people

Erez ChimovitsDirector · Director at ADARx Pharmaceuticals, filing Form 4 there in the last year
Carl L. GordonDirector and 10% owner · Director and 10% owner at ADARx Pharmaceuticals, filing Form 4 there in the last year
ORBIMED ADVISORS LLCDirector and 10% owner · Director and 10% owner at ADARx Pharmaceuticals, filing Form 4 there in the last year
LAV Biosciences Fund V, L.P.10% owner · 10% owner at ADARx Pharmaceuticals, filing Form 4 there in the last year
Simeon GeorgeDirector · Director and 10% owner at ADARx Pharmaceuticals, filing Form 4 there in the last year